This includes anxiety- and depression-like behaviors in the EPM and FST, deficits in spatial working memory and extradimensional attention set-shifting, and increased enrichment of acH4K12 and RNA Polymerase II at the Gαq gene promotor leading to increased transcription of the Gαq gene. The gene discussed is GNAQ; the disease is depressive symptom measurement.